It is now recognized that several species of bacteria may develop resistance to the antibacterial action of the sulfonamides. Strauss, Dingle, and Finland (1) have shown that pathogenic strains of staphylococci may become resistant in vitro by exposing cultures to increasing concentrations of the drugs. Vivino and Spink (2) confirmed these observations, and also pointed out that the development of sulfonamide-resistant staphylococci may take place in the human body. Up to the present time, we have isolated 28 strains of coagulase-positive staphylococci from 24 patients, which showed varying degrees of sulfonamideresistance. A description of these investigations and their clinical significance will be presented elsewhere (3).The mechanism whereby bacteria become adapted to grow in the presence of the sulfonamides has been the subject of numerous investigations. The observations of Woods (4) first suggested that para-aminobenzoic acid (PABA) was synthesized by certain species of organisms, and that PABA, an essential bacterial metabolite, competed with the chemically related sulfonamides for a position in a bacterial enzyme system. MacLeod (5) observed that cultures of a sulfonamide-resistant strain of Type I pneumococcus yielded a filtrate which inhibited the antibacterial action of sulfapyridine for B. coli to a greater degree than a filtrate prepared from the parent sulfonamide-sensitive strain. Mirick (6) utilized a suspension of a soil bacillus, which could be specifically adapted to oxidize PABA, and found that this suspension rapidly destroyed the diazotizable sulfonamide-inhibiting substance present in the filtrate prepared from a sulfonamide-resistant strain of pneumococcus. More recently Mirick (7) has presented a method for quantitating small amounts of PABA with the aid of specific adapted enzymes of this same soil bacillus. Landy and his associates (8) have investigated with a microbiological assay two sulfonamideresistant strains of staphylococcus supplied by us, and reported that the sulfonamide inhibitor elaborated by these strains was PABA.Up to the present time, there has not appeared any confirmatory evidence in support of Landy's conclusion that the antisulfonamide action of staphylococci is related to the synthesis of PABA by the bacterial cells. The purpose of this report is to present the results of observations showing that the resistance 331